{"organizations": [], "uuid": "4a4048236da511de18058a6ce2777660c6a193a3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180411.html", "section_title": "Archive News &amp; Video for Wednesday, 11 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/shire-ma-takeda-pharma/takeda-sounding-out-banks-for-loans-to-buy-shire-sources-idUST9N1QR01T", "country": "US", "domain_rank": 408, "title": "Takeda sounding out banks for loans to buy Shire - sources", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.002, "site_type": "news", "published": "2018-04-12T11:45:00.000+03:00", "replies_count": 0, "uuid": "4a4048236da511de18058a6ce2777660c6a193a3"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/shire-ma-takeda-pharma/takeda-sounding-out-banks-for-loans-to-buy-shire-sources-idUST9N1QR01T", "ord_in_thread": 0, "title": "Takeda sounding out banks for loans to buy Shire - sources", "locations": [], "entities": {"persons": [{"name": "takeda", "sentiment": "negative"}, {"name": "shire", "sentiment": "none"}, {"name": "sam nussey", "sentiment": "none"}, {"name": "chang-ran kim", "sentiment": "none"}], "locations": [{"name": "tokyo", "sentiment": "none"}, {"name": "japan", "sentiment": "none"}, {"name": "uk", "sentiment": "none"}], "organizations": [{"name": "takeda pharmaceutical co ltd", "sentiment": "negative"}, {"name": "shire", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "kyodo news", "sentiment": "none"}, {"name": "sumitomo mitsui financial group inc.", "sentiment": "none"}, {"name": "sumitomo mitsui banking corp", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "TOKYO, April 12 (Reuters) - Takeda Pharmaceutical Co Ltd has sounded out creditors for loans, including its main bank, Sumitomo Mitsui Banking Corp, to buy London-listed rare disease specialist Shire, two sources with direct knowledge of the matter said on Thursday.\nKyodo News reported earlier that Takeda, Japan’s top drugmaker, was looking for loans of several trillion yen (tens of billions of dollars) in total from multiple banks.\nTakeda said last month it was “at a preliminary and exploratory stage” of considering a bid. Under UK takeover rules, it has until April 25 to decide whether to make a bid.\nThe company was not immediately available for comment.\nSumitomo Mitsui Banking Corp is the core banking unit of Sumitomo Mitsui Financial Group Inc.\n$1 = 106.8400 yen Reporting by Sam Nussey and Taro Fuse Editing by Chang-Ran Kim\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-12T11:45:00.000+03:00", "crawled": "2018-04-12T13:52:37.006+03:00", "highlightTitle": ""}